We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Royal Philips said Tuesday it had reached an enrollment goal of 2,500 patients in its Sleep Apnea cardioVascular Endpoints (SAVE) trial. Preliminary results are expected in 2016. Read More
Kennesaw, Ga.-based CryoLife is expanding its footprint in the Asia/Pacific market, establishing CryoLife Asia Pacific as a wholly owned subsidiary of the parent corporation. Read More
Cardiologists will be looking to Europe for pipeline updates this year, particularly on Thoratec’s HeartMate III and HeartWare’s MVAD pump, analysts say. Read More
Amgen could not certify to an FDA inspector that it had evaluated a contractor that serviced its equipment, according to a recent warning letter. Read More
Baxter Healthcare landed an FDA warning letter that includes multiple repeat observations and issues related to test methods, CAPAs and over-infusion with its elastomeric infusion systems. Read More